ECD is characterized by mutations in multiple MAPK pathway genes, such as BRAF V600E, ARAF, NRAS, KRAS, MAP2K1, and PIK3CA, and BRAF V600E mutations occur in approximately 50%–60% of ECD. This evidence concerns the gene KRAS and familial atrioventricular septal defect.